The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross‐Sectional Study
Health Science Reports · 2025-05 · 8 (5)
DOI: 10.1002/hsr2.70680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 05.05.2025. Verfasst von Zohreh Khezeli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, School of Public Health Tehran University of Medical Sciences Tehran Iran. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Background and Aims Diverse HPV 16 variants have been known to vary in geographic distribution and oncogenic potential. On this point, the nucleotide changes of the E6 gene were studied to find lineages of HPV 16 in normal, premalignant, and malignant stages of uterine cervical samples.
Methods
In this study, 120 HPV 16‐infected samples were investigated using PCR and sequencing.
Results
In our samples, three lineages A, C, and D were found and lineage D was predominant (79.2%) followed by lineages A (20%) and C (0.8%). Concerning the association between histopathological stages and lineages, no statistically important differences were found.
Conclusion
Our finding revealed that two lineages A and D were circulating, with the dominancy of lineage, in Tehran, Iran. This finding emphasizes the geographic diversity of distinct HPV 16 (sub)lineages is different in the world.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Virology, School of Public Health Tehran University of Medical Sciences Tehran Iran.
- Department of Virology Pasteur Institute of Iran Tehran Iran.
ORCID-Profile: Somayeh Jalilvand
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Khezeli, Z., Shoja, Z., Kaffashian, M., Soleimani-Jelodar, R., & Jalilvand, S. (2025). The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross‐Sectional Study. Health Science Reports, 8(5). https://doi.org/10.1002/hsr2.70680
Vancouver
Khezeli Z, Shoja Z, Kaffashian M, Soleimani-Jelodar R, Jalilvand S. The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross‐Sectional Study. Health Science Reports. 2025;8(5). doi:10.1002/hsr2.70680
BibTeX
@article{Khezeli2025,
author = {Khezeli, Zohreh and Shoja, Zabihollah and Kaffashian, Mehrnaz and Soleimani-Jelodar, Rahim and Jalilvand, Somayeh},
title = {The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross‐Sectional Study},
journal = {Health Science Reports},
year = {2025},
volume = {8},
number = {5},
doi = {10.1002/hsr2.70680}
}
EUVIMED